[Ac-Tyr 1 ,D-Phe 2 ]GRF 1-29, amide (human)

Name [Ac-Tyr 1 ,D-Phe 2 ]GRF 1-29, amide (human)
Supplier Tocris Bioscience
Catalog 2903
Prices $189.00
Sizes 500 µg
Function Type Antagonist
Cas Number 93965-89-0
Formula C157H252N44O43S
Molecular Weight 3475
Description VIP receptor antagonist; inhibits [ 125 I]iodo-VIP binding and selectively inhibits VIP- and GRF-induced effects on adenylyl cyclase.
Supplier Page Shop

Product References

Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with - Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with

Waelbroeck M, Robberecht P, Coy DH, Camus JC, De Neef P, Christophe J. Endocrinology. 1985 Jun;116(6):2643-9.

Evidence that endogenous vasoactive intestinal peptide (VIP) is involved in the - Evidence that endogenous vasoactive intestinal peptide (VIP) is involved in the

Nowak M, Markowska A, Nussdorfer GG, Tortorella C, Malendowicz LK. Neuropeptides. 1994 Nov;27(5):297-303.